How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,342 results for

Myocardial Infarction Stabilization

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

321. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures

been two cohort studies, six RCTs, and five meta-analyses published since 2013 that report mortality and cardiovascular outcomes, such as myocardial infarction, stroke, CVD risk and events, hypertension (HTN), and dyslipidemia (31-43). Despite heterogeneity in study design, these data favor significantly improved CVD outcomes in patients undergoing bariatric surgery. DiaSurg 2, a randomized controlled multicenter trial comparing RYGB versus medical treatment in German patients with insulin (...) -requiring T2D with BMI 26–35 kg/m 2 , is currently underway (44). The primary endpoint is composite time-to-event using 8-year data, DOI:10.4158/GL-2019-0406 © 2019 AACE. 19 including CVD mortality, myocardial infarction, coronary bypass, percutaneous coronary intervention, nonfatal stroke, amputation, and surgery for peripheral atherosclerotic artery disease. The evolving role of bariatric procedures, or more generally speaking gastrointestinal (GI) procedures to decrease cardiometabolic risk, is more

2019 American Association of Clinical Endocrinologists

322. Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association (Full text)

therapy. Cardiovascular complications of cancer therapy significantly contribute to the global burden of CVD, and the success in treating cancer has produced a large cohort of cancer survivors with increased risk of chronic multisystemic diseases. Life-threatening complications of congestive heart failure, thrombogenesis, pericardial disease, hypertension, myocardial ischemia, cardiac arrhythmias, and vasospasm , have all been linked to cancer therapies such as cytotoxic chemotherapies, molecularly (...) emphasizes toxicity related to myocardial injury with the use of in vitro hiPSC-CM preparations. Contractile dysfunction, usually the first clinical manifestation of drug-induced cardiotoxicity, is often associated with structural cardiotoxicity. The detection of structural cardiotoxicity with hiPSC-CMs in vitro may guide the evaluation of cardiac liabilities, the synthesis of safer molecules, and the design of more informative early clinical studies. The basic aspects of electrophysiological

2019 American Heart Association PubMed abstract

323. Standardization of Spirometry

for Spirometry Due to increases in myocardial demand or changes in blood pressure Acute myocardial infarction within 1 wk Systemic hypotension or severe hypertension Significant atrial/ventricular arrhythmia Noncompensated heart failure Uncontrolled pulmonary hypertension Acute cor pulmonale Clinically unstable pulmonary embolism History of syncope related to forced expiration/cough Due to increases in intracranial/intraocular pressure Cerebral aneurysm Brain surgery within 4 wk Recent concussion (...) and lung. The physical effort required can increase myocardial demand. Caution must be used for patients with medical conditions that could be adversely affected by these physiological consequences ( ). Although such risks are likely to be minimal for spirometry in most patients ( ), the potential risks associated with testing should always be weighed against the benefit of obtaining information about lung function ( , , ). Spirometry should be discontinued if the patient experiences pain during

2019 American Thoracic Society

324. AACE/ACE Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care

Brain injury Traumatic brain injury a Sports-related head trauma a Blast injury a Infiltrative/granulomatous disease Langerhans cell histiocytosis Autoimmune hypophysitis (primary, secondary) Sarcoidosis Tuberculosis Amyloidosis Surgery to the sella, suprasellar, and parasellar region a Cranial irradiation a Central nervous system infections Bacteria, viruses, fungi, parasites Infarction/hemorrhage Apoplexy Sheehan’s syndrome Subarachnoid hemorrhage Ischemic stroke Snake bite Empty sella

2019 American Association of Clinical Endocrinologists

325. Male Sexual Dysfunction

-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol, 2009. 55: 121. 147. Khera, M., et al. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol, 2014. 65: 115. 148. Corona, G., et al. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf, 2014. 13: 1327. 149. Baillargeon, J., et al. Risk of Myocardial Infarction in Older Men Receiving Testosterone (...) and meta-analysis. J Clin Endocrinol Metab, 2010. 95: 2560. 153. Haddad, R.M., et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc, 2007. 82: 29. 154. Vigen, R., et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA, 2013. 310: 1829. 155. Sohn, M., et al. Standard operating procedures for vascular surgery in erectile dysfunction

2019 European Association of Urology

328. AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm (Full text)

blockers, calcium channel blockers (CCBs), and thiazide diuretics are favored choices for first-line treatment ( ). The selection of medications should be based on factors such as the presence of albuminuria, ASCVD, heart failure, or post–myocardial infarction status as well as patient race/ethnicity, possible metabolic side effects, pill burden, and cost. Because ACEIs and ARBs can slow progression of nephropathy and retinopathy, they are preferred for patients with T2D ( , ). Patients with heart (...) with clinical ASCVD and diabetes. When added to maximal statin therapy, these once-or twice-monthly injectable agents reduce LDL-C by approximately 50%, raise HDL-C, and have favorable effects on other lipids ( ). In the FOURIER (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk) study, evolocumab significantly reduced the risk of myocardial infarction, stroke, and coronary revascularization ( ), and similar effects were seen with alirocumab in ODYSSEY Outcomes

2019 American Association of Clinical Endocrinologists PubMed abstract

329. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

of Table 2. Relative Contraindications for Spirometry Due to increases in myocardial demand or changes in blood pressure Acute myocardial infarction within 1 wk Systemic hypotension or severe hypertension Signi?cant atrial/ventricular arrhythmia Noncompensated heart failure Uncontrolled pulmonary hypertension Acute cor pulmonale Clinically unstable pulmonary embolism History of syncope related to forced expiration/cough Due to increases in intracranial/intraocular pressure Cerebral aneurysm Brain (...) pressures generated in the thorax and their impact on abdominal and thoracic organs, venous return and systemic blood pressure, and expansion of the chest wall and lung. The physical effort required can increase myocardial demand. Caution must be used for patients with medical conditions that could be adversely affected by these physiological consequences (Table 2). Although such risksarelikelytobeminimalforspirometry in most patients (21), the potential risks associated with testing should always

2020 European Respiratory Society

330. EANM Practice Guideline/SNMMI Procedure Standard for Dopaminergic Imaging in Parkinsonian Syndromes 1.0 (Full text)

resolution and count rate capability with respect to parallel-hole collimators. Medium energy collimators have a lower spatial resolution although they have advantages due to septal penetration [ ]. If available, collimator sets specifically adapted to the characteristics of 123 I may be used. [ ] Acquisition protocol Timing 1. SPECT should be started when the ratio of striatal-to-occipital tracer binding is stable [ ]. In fact, waiting for stability of the ratio guarantees the most reliable data from (...) is controversial, and ill-defined. Basal ganglia vascular lesions are very common and will cause parkinsonism in only a minority of patients, and neither infarct site nor the size can predict the clinical presentation. In the literature, DAT ligand binding has been described as normal or only slightly diminished, except when an infarct directly involves a striatal structure. Even then, a deficit from an infarct often gives a “punched-out” appearance. The pattern has a different aspect with respect

2020 European Association of Nuclear Medicine PubMed abstract

331. On Versus Off Pump Myocardial Revascularization Study

, prospective, randomized, parallel, trial.Patients indicated for elective or urgent isolated coronary artery bypass graft with additive European System for Cardiac Operative Risk Evaluation ≥ 6 were enrolled. Patients in cardiogenic shock were excluded. Patients were randomly assigned either to coronary artery bypass surgery with cardiopulmonary bypass (ON arm) or to off-pump coronary artery bypass graft (OFF arm). The composite primary end point included operative mortality, myocardial infarction, stroke (...) : Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: ON Pump vs OFF Pump Myocardial Revascularization in High Risk Patients: a Randomized Study Study Start Date : September 2006 Actual Primary Completion Date : June 2010 Actual Study Completion Date : June 2011 Arms and Interventions Go to Arm Intervention/treatment Experimental: Off-pump bypass surgery Off-pump coronary artery bypass graft (OPCAB) using mandatory a stabilization device and advisable

2011 Clinical Trials

332. Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment

Association functional class II - IV) despite stabile optimal medical therapy. Wide QRS ≥ 120 milliseconds on standard ECG. LV systolic dysfunction (EF ≤ 35%). Written informed consent. Accepted for CRT-P or CRT-D treatment Exclusion Criteria: Life expectancy < 12 months. Recent myocardial infarction (< 3 months). Significant valve disease Chronic atrial fibrillation Pregnancy Severely impaired renal function (estimated glomerular filtration rate (eGFR) < 30 ml/min) Unable to give written informed consent (...) Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2011 Clinical Trials

333. Treatment of Hypertension in Association With Diabetes Mellitus

. Analysis and reporting of factorial trials: a systematic review. JAMA 2003;289:2545-53. Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials. Circulation 2011;123:2799-810, 9 p following 810. Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes (...) in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997;349:1787-92. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin dependent

2018 Hypertension Canada

335. Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease

between 40 and 60% of patients with ST-segment elevation myocardial infarction (STEMI) and has been associated to a worse prognosis. Multivessel revascularization offers a myriad of potential advantages as enhance of the collateral blood flow, greater myocardial salvage, the stabilization of other lesions that can be potentially vulnerable, and the achievement of a complete revascularization, factor that is associated with a better prognosis. On the other hand, the prolongation of procedural duration (...) Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2010 Clinical Trials

336. Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)

Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI) Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results (...) information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI) (VIRHISTAMI) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators

2010 Clinical Trials

337. Leucine125Valine (Leu125Val) Gene Polymorphism of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and Myocardial Infarction in Indian Population (Full text)

Leucine125Valine (Leu125Val) Gene Polymorphism of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and Myocardial Infarction in Indian Population Platelet-endothelial cell adhesion molecule-1 (PECAM-1) has role in atherosclerotic plaque development as well as in thrombosis leading to myocardial infarction (MI). Present study was aimed to analyse the association of PECAM-1 Leu125Val gene polymorphism with MI in Indian population. Subjects included healthy individuals as control (N = 116 (...) ) and MI patients (N = 100) divided into two groups; MI patients at presentation of the acute event (MI-Group-1, N = 46) and patients with recent event of MI stabilized with treatment 4.5 days from their symptoms (MI-Group-2, N = 54). The difference in the distribution of Leu125Val genotype frequencies of controls and patients did not reach statistical significance. However Leu allele frequency (0.57) was more associated with MI patients as compared to control (0.504). sPECAM-1 levels were

2010 Indian Journal of Clinical Biochemistry PubMed abstract

338. Cytokine Combination Therapy with Erythropoietin and Granulocyte Colony Stimulating Factor in a Porcine Model of Acute Myocardial Infarction (Full text)

Cytokine Combination Therapy with Erythropoietin and Granulocyte Colony Stimulating Factor in a Porcine Model of Acute Myocardial Infarction Erythropoietin (EPO) and granulocyte colony stimulating factor (GCSF) have generated interest as novel therapies after myocardial infarction (MI), but the effect of combination therapy has not been studied in the large animal model. We investigated the impact of prolonged combination therapy with EPO and GCSF on cardiac function, infarct size, and vascular (...) density after MI in a porcine model.MI was induced in pigs by a 90 min balloon occlusion of the left anterior descending coronary artery. 16 animals were treated with EPO+GCSF, or saline (control group). Cardiac function was assessed by echocardiography and pressure-volume measurements at baseline, 1 and 6 weeks post-MI. Histopathology was performed 6 weeks post-MI.At week 6, EPO+GCSF therapy stabilized left ventricular ejection fraction, (41 ± 1% vs. 33 ± 1%, p < 0.01) and improved diastolic function

2010 Cardiovascular Drugs and Therapy PubMed abstract

339. [Efficiency of ACE inhibitors, beta adrenoblocker and antihypoxant in the phase of stationary rehabilitation of patients with myocardial infarction working in environmentally unfriendly conditions]. (Abstract)

[Efficiency of ACE inhibitors, beta adrenoblocker and antihypoxant in the phase of stationary rehabilitation of patients with myocardial infarction working in environmentally unfriendly conditions]. The aim of this work was to study effect of fosinopril combined with propranolol or cytomack on ecoendotoxicosis, size of myocardial infarction (MI), left ventricular (LV) systolic function, and clinical picture of stationary phase MI in patients working in environmentally unfriendly conditions. 42 (...) functions (ESV, EDV, EF), size of MI (total ST, AST, total Rh), and clynical symptoms. It was shown that patients working in environmentally unfriendly conditions were characterized by high degree of PSD. In group 1 they exhibited reduction of PSD, total ST, AST, ESV, EDV and increase of total Rh and EF. Decreased systolic and diastolic AP did not lead to clinically significant hypotension. Patients of group 2 showed stabilization of AP, decrease of PSD, total ST, AST, ESV, EDV and increase of total Rh

2010 Klinicheskaia meditsina Controlled trial quality: uncertain

340. Acute myocardial infarction hospitalization in the United States, 1979 to 2005. (Abstract)

Survey and US civilian population from 1979 to 2005, aggregated by 3-year groupings. We also assessed comorbid, complications, cardiac procedure use, and in-hospital case-fatality rates.Age-adjusted hospitalization rate for acute myocardial infarction identified by primary International Classification of Diseases code was 215 per 100,000 people in 1979-1981 and increased to 342 in 1985-1987. Thereafter, the rate stabilized for the next decade and then declined slowly after 1996 to 242 in 2003-2005 (...) Acute myocardial infarction hospitalization in the United States, 1979 to 2005. We reported earlier that there was no decline of acute myocardial infarction hospitalization from 1988 to 1997. We now extend these observations to document trends in acute myocardial infarction hospitalization rates and in-hospital case-fatality rates for 27 years from 1979 to 2005.We determined hospitalization rates for acute myocardial infarction by age and gender using data from the National Hospital Discharge

2010 American Journal of Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>